| Authors: |
Strand V; Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA, USA., Kalunian KC; University of California, San Diego, La Jolla, CA, USA., Wai Lee K; GMAP, AstraZeneca, Cambridge, UK., Seo C; BioPharmaceuticals Medical Evidence, AstraZeneca, Gaithersburg, MD, USA., Abreu G; BioPharmaceuticals R&D, AstraZeneca, Gothenburg 43183, Sweden., Tummala R; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Al-Mossawi H; BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Duncan EA; BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA., Lindholm C; BioPharmaceuticals R&D, AstraZeneca, Gothenburg 43183, Sweden. Electronic address: catharina.lindholm@astrazeneca.com. |
